Boris Shekunov

Boris Shekunov is currently the Scientific Director at Pfizer, specializing in process design and optimization, computational modeling, and various aspects of drug delivery. Their extensive academic background includes a PhD in Physical and Mathematical Sciences from Moscow State University and multiple roles in pharmaceutical sciences at prestigious institutions such as the University of Bradford and De Montfort University. Over the years, Boris has held senior positions at leading companies like Bristol-Myers Squibb and Takeda, contributing to research and development in solid-state chemistry and analytical technology. Prior to their current role, they served as Director of Process Development at Seagen and held significant roles at Shire Pharmaceuticals and Ferro Corporation.